Share Price and Basic Stock Data
Last Updated: November 28, 2025, 7:23 am
| PEG Ratio | 13.05 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Hindustan Unilever Ltd (HUL), a leader in the personal care industry, reported a market capitalization of ₹5,69,905 Cr and a share price of ₹2,426. The company displayed a robust revenue growth trajectory, with sales rising from ₹52,446 Cr in FY 2022 to ₹60,580 Cr in FY 2023, and further to ₹61,896 Cr in FY 2024. The trailing twelve months (TTM) revenue stood at ₹64,243 Cr, reflecting a consistent upward trend. Quarterly sales data indicates resilience, with sales figures fluctuating between ₹15,215 Cr and ₹15,707 Cr from March 2023 to June 2025. The operating profit margin (OPM) remained stable around 23% to 24%, underscoring HUL’s ability to maintain profitability amidst fluctuating expenses, which are projected to increase at a slower pace than sales. This consistent revenue performance positions HUL favorably against industry peers, which typically experience more volatile revenue streams due to market dynamics.
Profitability and Efficiency Metrics
HUL’s profitability metrics underline its operational efficiency and competitive advantage within the personal care sector. The company recorded a net profit of ₹10,926 Cr for the TTM, reflecting a healthy net profit margin of 16.91% in FY 2025. The return on equity (ROE) stood at 20.7%, while the return on capital employed (ROCE) was reported at 27.8%, both indicating effective utilization of shareholders’ funds and strong operational performance. The interest coverage ratio (ICR) was exceptionally high at 40.17x, showcasing HUL’s ability to meet its interest obligations comfortably. Additionally, the cash conversion cycle (CCC) was recorded at -71 days, indicating efficient management of working capital. HUL’s operating profit increased to ₹14,843 Cr in FY 2025, supporting its consistent OPM of around 24%. These figures position HUL as a strong player in the industry, with profitability metrics well above typical sector averages.
Balance Sheet Strength and Financial Ratios
HUL’s balance sheet reflects a solid financial foundation, with total assets amounting to ₹79,863 Cr and total liabilities at ₹79,863 Cr, resulting in a healthy equity base. The company’s reserves stood at ₹48,481 Cr, while borrowings were relatively low at ₹1,775 Cr, indicating minimal leverage and a conservative approach to financing. The price-to-book value (P/BV) ratio was reported at 10.75x, suggesting that the market values HUL significantly above its book value, which is indicative of strong investor confidence. The current ratio was recorded at 1.33, demonstrating adequate liquidity to cover short-term liabilities. Furthermore, the asset turnover ratio of 0.79 reflects efficient asset utilization. HUL’s financial ratios, including a low debt-to-equity ratio and a robust interest coverage ratio, position it favorably against its peers, enhancing its appeal to potential investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Hindustan Unilever reveals a stable and confident investor base, with promoters holding a consistent 61.90% stake. Foreign Institutional Investors (FIIs) accounted for 10.79%, while Domestic Institutional Investors (DIIs) held 15.62% of the shares. This distribution indicates a balanced approach among institutional investors, reflecting confidence in HUL’s long-term growth prospects. The number of shareholders stood at 10,95,447, showing a slight decline from previous quarters, which may suggest a consolidation phase among retail investors. The dividend payout ratio has increased to 116.94%, significantly above sector norms, indicating HUL’s commitment to returning value to shareholders. This strong dividend policy, combined with consistent profits, enhances investor confidence and underscores HUL’s financial health and operational success.
Outlook, Risks, and Final Insight
Looking ahead, Hindustan Unilever is well-positioned to capitalize on growth opportunities in the personal care sector, supported by its strong brand portfolio and efficient operational metrics. However, risks exist, including potential fluctuations in raw material costs and changing consumer preferences, which could impact margins. Additionally, increasing competition from both established and emerging brands poses a challenge to market share. HUL’s strong balance sheet and effective cost management strategies should mitigate these risks. In a scenario of continued revenue growth and stable margins, HUL could enhance its market leadership further. Conversely, if external pressures intensify or operational efficiencies decline, the company may face challenges in maintaining its profitability. Overall, HUL’s performance metrics and strategic positioning suggest a resilient outlook despite the inherent risks in the consumer goods sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Hindustan Unilever Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Honasa Consumer Ltd | 9,367 Cr. | 288 | 334/190 | 75.3 | 38.8 | 0.00 % | 7.44 % | 5.51 % | 10.0 |
| Ambica Agarbathies Aroma & Industries Ltd | 44.3 Cr. | 25.8 | 37.0/23.3 | 86.9 | 65.2 | 0.00 % | 7.49 % | 0.45 % | 10.0 |
| Ador Multi Products Ltd | 106 Cr. | 110 | 119/23.4 | 32.5 | 0.00 % | 11.4 % | 3.09 % | 10.0 | |
| Kaya Ltd | 621 Cr. | 403 | 488/204 | 60.9 | 0.00 % | 2.50 % | % | 10.0 | |
| Jyothy Labs Ltd | 11,193 Cr. | 305 | 433/268 | 30.6 | 55.8 | 1.15 % | 24.6 % | 19.0 % | 1.00 |
| Industry Average | 71,881.36 Cr | 1,946.30 | 57.09 | 112.56 | 0.74% | 29.21% | 23.91% | 4.94 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 14,624 | 15,144 | 15,597 | 15,215 | 15,496 | 15,623 | 15,567 | 15,210 | 15,707 | 15,926 | 15,818 | 15,670 | 16,514 |
| Expenses | 11,222 | 11,665 | 11,903 | 11,643 | 11,832 | 11,828 | 11,902 | 11,675 | 11,965 | 12,139 | 12,123 | 12,052 | 12,797 |
| Operating Profit | 3,402 | 3,479 | 3,694 | 3,572 | 3,664 | 3,795 | 3,665 | 3,535 | 3,742 | 3,787 | 3,695 | 3,618 | 3,717 |
| OPM % | 23% | 23% | 24% | 23% | 24% | 24% | 24% | 23% | 24% | 24% | 23% | 23% | 23% |
| Other Income | 121 | 80 | 7 | 240 | 146 | 178 | 184 | 309 | 209 | 203 | 740 | 171 | 74 |
| Interest | 28 | 28 | 29 | 29 | 50 | 88 | 91 | 105 | 93 | 110 | 112 | 80 | 127 |
| Depreciation | 281 | 272 | 293 | 291 | 286 | 297 | 313 | 320 | 329 | 338 | 341 | 347 | 361 |
| Profit before tax | 3,214 | 3,259 | 3,379 | 3,492 | 3,474 | 3,588 | 3,445 | 3,419 | 3,529 | 3,542 | 3,982 | 3,362 | 3,303 |
| Tax % | 26% | 18% | 27% | 26% | 26% | 26% | 27% | 25% | 26% | 27% | 25% | 26% | 16% |
| Net Profit | 2,391 | 2,670 | 2,481 | 2,601 | 2,556 | 2,657 | 2,508 | 2,561 | 2,612 | 2,595 | 2,989 | 2,475 | 2,768 |
| EPS in Rs | 10.13 | 11.34 | 10.53 | 11.07 | 10.87 | 11.30 | 10.68 | 10.89 | 11.11 | 11.03 | 12.70 | 10.49 | 11.73 |
Last Updated: August 2, 2025, 1:20 am
Below is a detailed analysis of the quarterly data for Hindustan Unilever Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 16,514.00 Cr.. The value appears strong and on an upward trend. It has increased from 15,670.00 Cr. (Mar 2025) to 16,514.00 Cr., marking an increase of 844.00 Cr..
- For Expenses, as of Jun 2025, the value is 12,797.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12,052.00 Cr. (Mar 2025) to 12,797.00 Cr., marking an increase of 745.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 3,717.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,618.00 Cr. (Mar 2025) to 3,717.00 Cr., marking an increase of 99.00 Cr..
- For OPM %, as of Jun 2025, the value is 23.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 23.00%.
- For Other Income, as of Jun 2025, the value is 74.00 Cr.. The value appears to be declining and may need further review. It has decreased from 171.00 Cr. (Mar 2025) to 74.00 Cr., marking a decrease of 97.00 Cr..
- For Interest, as of Jun 2025, the value is 127.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 80.00 Cr. (Mar 2025) to 127.00 Cr., marking an increase of 47.00 Cr..
- For Depreciation, as of Jun 2025, the value is 361.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 347.00 Cr. (Mar 2025) to 361.00 Cr., marking an increase of 14.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 3,303.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,362.00 Cr. (Mar 2025) to 3,303.00 Cr., marking a decrease of 59.00 Cr..
- For Tax %, as of Jun 2025, the value is 16.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Mar 2025) to 16.00%, marking a decrease of 10.00%.
- For Net Profit, as of Jun 2025, the value is 2,768.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,475.00 Cr. (Mar 2025) to 2,768.00 Cr., marking an increase of 293.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 11.73. The value appears strong and on an upward trend. It has increased from 10.49 (Mar 2025) to 11.73, marking an increase of 1.24.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 5:54 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 29,234 | 31,972 | 32,186 | 33,162 | 35,545 | 39,310 | 39,783 | 47,028 | 52,446 | 60,580 | 61,896 | 63,121 | 64,243 |
| Expenses | 24,475 | 26,560 | 26,276 | 26,834 | 28,046 | 30,430 | 29,922 | 35,402 | 39,589 | 46,433 | 47,237 | 48,278 | 49,487 |
| Operating Profit | 4,759 | 5,412 | 5,910 | 6,328 | 7,499 | 8,880 | 9,861 | 11,626 | 12,857 | 14,147 | 14,659 | 14,843 | 14,756 |
| OPM % | 16% | 17% | 18% | 19% | 21% | 23% | 25% | 25% | 25% | 23% | 24% | 24% | 23% |
| Other Income | 792 | 1,247 | 486 | 606 | 353 | 322 | 424 | 170 | 219 | 448 | 817 | 1,322 | 1,316 |
| Interest | 41 | 18 | 17 | 35 | 26 | 33 | 118 | 117 | 106 | 114 | 334 | 395 | 448 |
| Depreciation | 296 | 322 | 353 | 432 | 520 | 565 | 1,002 | 1,074 | 1,091 | 1,137 | 1,216 | 1,355 | 1,407 |
| Profit before tax | 5,215 | 6,320 | 6,026 | 6,467 | 7,306 | 8,604 | 9,165 | 10,605 | 11,879 | 13,344 | 13,926 | 14,415 | 14,217 |
| Tax % | 24% | 31% | 31% | 31% | 28% | 30% | 26% | 25% | 25% | 24% | 26% | 26% | |
| Net Profit | 3,956 | 4,376 | 4,151 | 4,490 | 5,227 | 6,060 | 6,756 | 7,999 | 8,892 | 10,143 | 10,282 | 10,671 | 10,926 |
| EPS in Rs | 18.24 | 20.17 | 19.18 | 20.68 | 24.09 | 27.97 | 31.17 | 34.03 | 37.79 | 43.07 | 43.74 | 45.32 | 46.35 |
| Dividend Payout % | 71% | 74% | 83% | 82% | 83% | 78% | 80% | 119% | 90% | 91% | 96% | 117% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 10.62% | -5.14% | 8.17% | 16.41% | 15.94% | 11.49% | 18.40% | 11.16% | 14.07% | 1.37% | 3.78% |
| Change in YoY Net Profit Growth (%) | 0.00% | -15.76% | 13.31% | 8.25% | -0.48% | -4.45% | 6.91% | -7.23% | 2.90% | -12.70% | 2.41% |
Hindustan Unilever Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 10% |
| 3 Years: | 6% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 9% |
| 3 Years: | 5% |
| TTM: | 3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 5% |
| 3 Years: | 1% |
| 1 Year: | -6% |
| Return on Equity | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 21% |
| 3 Years: | 20% |
| Last Year: | 21% |
Last Updated: September 4, 2025, 9:25 pm
Balance Sheet
Last Updated: November 9, 2025, 1:30 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 216 | 216 | 216 | 216 | 216 | 216 | 216 | 235 | 235 | 235 | 235 | 235 | 235 |
| Reserves | 3,321 | 3,811 | 6,357 | 6,528 | 7,065 | 7,651 | 8,013 | 47,439 | 48,826 | 50,069 | 50,983 | 49,167 | 48,481 |
| Borrowings | 46 | 43 | 177 | 277 | 0 | 99 | 0 | 0 | 1,043 | 1,219 | 1,484 | 1,648 | 1,775 |
| Other Liabilities | 10,171 | 10,359 | 8,043 | 8,685 | 10,581 | 10,663 | 11,924 | 21,066 | 20,402 | 21,554 | 25,787 | 28,813 | 31,543 |
| Total Liabilities | 13,754 | 14,430 | 14,793 | 15,706 | 17,862 | 18,629 | 20,153 | 68,740 | 70,506 | 73,077 | 78,489 | 79,863 | 82,034 |
| Fixed Assets | 2,746 | 2,821 | 3,258 | 4,419 | 4,528 | 4,715 | 5,479 | 51,443 | 51,473 | 52,678 | 53,744 | 54,335 | 58,126 |
| CWIP | 373 | 516 | 408 | 229 | 461 | 406 | 597 | 745 | 1,313 | 1,132 | 1,025 | 1,009 | 1,022 |
| Investments | 2,838 | 3,025 | 2,592 | 3,794 | 2,873 | 2,716 | 1,255 | 2,709 | 3,521 | 2,882 | 4,625 | 3,810 | 3,958 |
| Other Assets | 7,797 | 8,067 | 8,535 | 7,264 | 10,000 | 10,792 | 12,822 | 13,843 | 14,199 | 16,385 | 19,095 | 20,709 | 18,928 |
| Total Assets | 13,754 | 14,430 | 14,793 | 15,706 | 17,862 | 18,629 | 20,153 | 68,740 | 70,506 | 73,077 | 78,489 | 79,863 | 82,034 |
Below is a detailed analysis of the balance sheet data for Hindustan Unilever Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 235.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 235.00 Cr..
- For Reserves, as of Sep 2025, the value is 48,481.00 Cr.. The value appears to be declining and may need further review. It has decreased from 49,167.00 Cr. (Mar 2025) to 48,481.00 Cr., marking a decrease of 686.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,775.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,648.00 Cr. (Mar 2025) to 1,775.00 Cr., marking an increase of 127.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 31,543.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28,813.00 Cr. (Mar 2025) to 31,543.00 Cr., marking an increase of 2,730.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 82,034.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 79,863.00 Cr. (Mar 2025) to 82,034.00 Cr., marking an increase of 2,171.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 58,126.00 Cr.. The value appears strong and on an upward trend. It has increased from 54,335.00 Cr. (Mar 2025) to 58,126.00 Cr., marking an increase of 3,791.00 Cr..
- For CWIP, as of Sep 2025, the value is 1,022.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,009.00 Cr. (Mar 2025) to 1,022.00 Cr., marking an increase of 13.00 Cr..
- For Investments, as of Sep 2025, the value is 3,958.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,810.00 Cr. (Mar 2025) to 3,958.00 Cr., marking an increase of 148.00 Cr..
- For Other Assets, as of Sep 2025, the value is 18,928.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20,709.00 Cr. (Mar 2025) to 18,928.00 Cr., marking a decrease of 1,781.00 Cr..
- For Total Assets, as of Sep 2025, the value is 82,034.00 Cr.. The value appears strong and on an upward trend. It has increased from 79,863.00 Cr. (Mar 2025) to 82,034.00 Cr., marking an increase of 2,171.00 Cr..
Notably, the Reserves (48,481.00 Cr.) exceed the Borrowings (1,775.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -42.00 | -38.00 | -172.00 | -271.00 | 7.00 | -91.00 | 9.00 | 11.00 | 11.00 | 13.00 | 13.00 | 13.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 13 | 12 | 14 | 12 | 13 | 17 | 11 | 14 | 16 | 19 | 18 | 22 |
| Inventory Days | 86 | 77 | 75 | 67 | 65 | 59 | 65 | 66 | 65 | 55 | 55 | 59 |
| Days Payable | 170 | 148 | 156 | 164 | 185 | 166 | 176 | 163 | 145 | 123 | 143 | 152 |
| Cash Conversion Cycle | -72 | -60 | -67 | -85 | -107 | -90 | -101 | -83 | -64 | -50 | -70 | -71 |
| Working Capital Days | -54 | -53 | -26 | -35 | -37 | -30 | -31 | -32 | -22 | -15 | -22 | -33 |
| ROCE % | 147% | 139% | 112% | 91% | 103% | 116% | 117% | 39% | 25% | 27% | 27% | 28% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Nifty 50 ETF | 16,489,465 | 2.21 | 4580.77 | 16,489,465 | 2025-04-22 17:01:36 | 0% |
| SBI BSE Sensex ETF | 11,802,512 | 2.62 | 3278.86 | 11,802,512 | 2025-04-22 17:01:36 | 0% |
| ICICI Prudential Value Discovery Fund | 5,658,246 | 3.13 | 1571.86 | 5,658,246 | 2025-04-22 17:01:36 | 0% |
| UTI Nifty 50 ETF | 4,782,594 | 2.21 | 1328.6 | 4,782,594 | 2025-04-22 17:01:36 | 0% |
| SBI Blue Chip Fund | 4,590,000 | 2.47 | 1275.1 | 4,590,000 | 2025-04-22 17:01:36 | 0% |
| UTI BSE Sensex ETF | 4,364,862 | 2.62 | 1212.6 | 4,364,862 | 2025-04-22 17:01:36 | 0% |
| ICICI Prudential Balanced Advantage Fund | 3,217,964 | 1.46 | 893.95 | 3,217,964 | 2025-04-22 17:01:36 | 0% |
| Nippon India ETF Nifty 50 BeES | 2,606,174 | 2.21 | 724 | 2,606,174 | 2025-04-22 09:14:30 | 0% |
| Kotak Flexicap Fund - Regular Plan | 2,600,000 | 1.36 | 722.28 | 2,600,000 | 2025-04-22 14:53:35 | 0% |
| Mirae Asset Large Cap Fund | 2,315,497 | 1.55 | 643.25 | 2,315,497 | 2025-04-22 17:01:36 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 45.32 | 43.74 | 43.07 | 37.79 | 34.03 |
| Diluted EPS (Rs.) | 45.32 | 43.74 | 43.07 | 37.79 | 34.03 |
| Cash EPS (Rs.) | 51.21 | 48.94 | 48.00 | 42.48 | 38.61 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 210.22 | 217.95 | 214.99 | 208.88 | 202.95 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 210.22 | 217.95 | 214.99 | 208.88 | 202.95 |
| Revenue From Operations / Share (Rs.) | 268.60 | 263.39 | 257.79 | 223.17 | 200.12 |
| PBDIT / Share (Rs.) | 67.52 | 65.85 | 62.39 | 55.81 | 51.22 |
| PBIT / Share (Rs.) | 61.76 | 60.67 | 57.55 | 51.17 | 46.65 |
| PBT / Share (Rs.) | 61.37 | 59.28 | 56.79 | 50.53 | 45.13 |
| Net Profit / Share (Rs.) | 45.44 | 43.77 | 43.17 | 37.84 | 34.04 |
| NP After MI And SOA / Share (Rs.) | 45.31 | 43.73 | 43.06 | 37.78 | 34.02 |
| PBDIT Margin (%) | 25.13 | 25.00 | 24.20 | 25.00 | 25.59 |
| PBIT Margin (%) | 22.99 | 23.03 | 22.32 | 22.92 | 23.30 |
| PBT Margin (%) | 22.84 | 22.50 | 22.03 | 22.64 | 22.55 |
| Net Profit Margin (%) | 16.91 | 16.61 | 16.74 | 16.95 | 17.00 |
| NP After MI And SOA Margin (%) | 16.87 | 16.60 | 16.70 | 16.92 | 17.00 |
| Return on Networth / Equity (%) | 21.55 | 20.06 | 20.11 | 18.09 | 16.77 |
| Return on Capital Employeed (%) | 22.91 | 21.72 | 22.14 | 20.29 | 19.01 |
| Return On Assets (%) | 13.33 | 13.09 | 13.84 | 12.59 | 11.62 |
| Asset Turnover Ratio (%) | 0.79 | 0.81 | 0.83 | 0.73 | 1.04 |
| Current Ratio (X) | 1.33 | 1.66 | 1.41 | 1.38 | 1.28 |
| Quick Ratio (X) | 1.07 | 1.34 | 1.06 | 1.01 | 0.95 |
| Inventory Turnover Ratio (X) | 4.61 | 4.66 | 4.73 | 4.25 | 4.86 |
| Dividend Payout Ratio (NP) (%) | 116.94 | 91.44 | 83.58 | 84.68 | 110.20 |
| Dividend Payout Ratio (CP) (%) | 103.74 | 81.77 | 75.14 | 75.41 | 97.15 |
| Earning Retention Ratio (%) | -16.94 | 8.56 | 16.42 | 15.32 | -10.20 |
| Cash Earning Retention Ratio (%) | -3.74 | 18.23 | 24.86 | 24.59 | 2.85 |
| Interest Coverage Ratio (X) | 40.17 | 46.33 | 128.61 | 123.73 | 102.87 |
| Interest Coverage Ratio (Post Tax) (X) | 27.26 | 31.78 | 90.55 | 85.25 | 71.42 |
| Enterprise Value (Cr.) | 523601.25 | 525697.75 | 596944.25 | 477659.75 | 566787.00 |
| EV / Net Operating Revenue (X) | 8.30 | 8.49 | 9.85 | 9.11 | 12.05 |
| EV / EBITDA (X) | 33.00 | 33.97 | 40.72 | 36.42 | 47.09 |
| MarketCap / Net Operating Revenue (X) | 8.41 | 8.61 | 9.93 | 9.18 | 12.15 |
| Retention Ratios (%) | -16.94 | 8.55 | 16.41 | 15.31 | -10.20 |
| Price / BV (X) | 10.75 | 10.41 | 11.95 | 9.81 | 11.98 |
| Price / Net Operating Revenue (X) | 8.41 | 8.61 | 9.93 | 9.18 | 12.15 |
| EarningsYield | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
After reviewing the key financial ratios for Hindustan Unilever Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 45.32. This value is within the healthy range. It has increased from 43.74 (Mar 24) to 45.32, marking an increase of 1.58.
- For Diluted EPS (Rs.), as of Mar 25, the value is 45.32. This value is within the healthy range. It has increased from 43.74 (Mar 24) to 45.32, marking an increase of 1.58.
- For Cash EPS (Rs.), as of Mar 25, the value is 51.21. This value is within the healthy range. It has increased from 48.94 (Mar 24) to 51.21, marking an increase of 2.27.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 210.22. It has decreased from 217.95 (Mar 24) to 210.22, marking a decrease of 7.73.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 210.22. It has decreased from 217.95 (Mar 24) to 210.22, marking a decrease of 7.73.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 268.60. It has increased from 263.39 (Mar 24) to 268.60, marking an increase of 5.21.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 67.52. This value is within the healthy range. It has increased from 65.85 (Mar 24) to 67.52, marking an increase of 1.67.
- For PBIT / Share (Rs.), as of Mar 25, the value is 61.76. This value is within the healthy range. It has increased from 60.67 (Mar 24) to 61.76, marking an increase of 1.09.
- For PBT / Share (Rs.), as of Mar 25, the value is 61.37. This value is within the healthy range. It has increased from 59.28 (Mar 24) to 61.37, marking an increase of 2.09.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 45.44. This value is within the healthy range. It has increased from 43.77 (Mar 24) to 45.44, marking an increase of 1.67.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 45.31. This value is within the healthy range. It has increased from 43.73 (Mar 24) to 45.31, marking an increase of 1.58.
- For PBDIT Margin (%), as of Mar 25, the value is 25.13. This value is within the healthy range. It has increased from 25.00 (Mar 24) to 25.13, marking an increase of 0.13.
- For PBIT Margin (%), as of Mar 25, the value is 22.99. This value exceeds the healthy maximum of 20. It has decreased from 23.03 (Mar 24) to 22.99, marking a decrease of 0.04.
- For PBT Margin (%), as of Mar 25, the value is 22.84. This value is within the healthy range. It has increased from 22.50 (Mar 24) to 22.84, marking an increase of 0.34.
- For Net Profit Margin (%), as of Mar 25, the value is 16.91. This value exceeds the healthy maximum of 10. It has increased from 16.61 (Mar 24) to 16.91, marking an increase of 0.30.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 16.87. This value is within the healthy range. It has increased from 16.60 (Mar 24) to 16.87, marking an increase of 0.27.
- For Return on Networth / Equity (%), as of Mar 25, the value is 21.55. This value is within the healthy range. It has increased from 20.06 (Mar 24) to 21.55, marking an increase of 1.49.
- For Return on Capital Employeed (%), as of Mar 25, the value is 22.91. This value is within the healthy range. It has increased from 21.72 (Mar 24) to 22.91, marking an increase of 1.19.
- For Return On Assets (%), as of Mar 25, the value is 13.33. This value is within the healthy range. It has increased from 13.09 (Mar 24) to 13.33, marking an increase of 0.24.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.79. It has decreased from 0.81 (Mar 24) to 0.79, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.33. This value is below the healthy minimum of 1.5. It has decreased from 1.66 (Mar 24) to 1.33, marking a decrease of 0.33.
- For Quick Ratio (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has decreased from 1.34 (Mar 24) to 1.07, marking a decrease of 0.27.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.61. This value is within the healthy range. It has decreased from 4.66 (Mar 24) to 4.61, marking a decrease of 0.05.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 116.94. This value exceeds the healthy maximum of 50. It has increased from 91.44 (Mar 24) to 116.94, marking an increase of 25.50.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 103.74. This value exceeds the healthy maximum of 50. It has increased from 81.77 (Mar 24) to 103.74, marking an increase of 21.97.
- For Earning Retention Ratio (%), as of Mar 25, the value is -16.94. This value is below the healthy minimum of 40. It has decreased from 8.56 (Mar 24) to -16.94, marking a decrease of 25.50.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is -3.74. This value is below the healthy minimum of 40. It has decreased from 18.23 (Mar 24) to -3.74, marking a decrease of 21.97.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 40.17. This value is within the healthy range. It has decreased from 46.33 (Mar 24) to 40.17, marking a decrease of 6.16.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 27.26. This value is within the healthy range. It has decreased from 31.78 (Mar 24) to 27.26, marking a decrease of 4.52.
- For Enterprise Value (Cr.), as of Mar 25, the value is 523,601.25. It has decreased from 525,697.75 (Mar 24) to 523,601.25, marking a decrease of 2,096.50.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 8.30. This value exceeds the healthy maximum of 3. It has decreased from 8.49 (Mar 24) to 8.30, marking a decrease of 0.19.
- For EV / EBITDA (X), as of Mar 25, the value is 33.00. This value exceeds the healthy maximum of 15. It has decreased from 33.97 (Mar 24) to 33.00, marking a decrease of 0.97.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 8.41. This value exceeds the healthy maximum of 3. It has decreased from 8.61 (Mar 24) to 8.41, marking a decrease of 0.20.
- For Retention Ratios (%), as of Mar 25, the value is -16.94. This value is below the healthy minimum of 30. It has decreased from 8.55 (Mar 24) to -16.94, marking a decrease of 25.49.
- For Price / BV (X), as of Mar 25, the value is 10.75. This value exceeds the healthy maximum of 3. It has increased from 10.41 (Mar 24) to 10.75, marking an increase of 0.34.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 8.41. This value exceeds the healthy maximum of 3. It has decreased from 8.61 (Mar 24) to 8.41, marking a decrease of 0.20.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hindustan Unilever Ltd:
- Net Profit Margin: 16.91%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.91% (Industry Average ROCE: 29.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 21.55% (Industry Average ROE: 23.91%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 27.26
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.07
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 54.4 (Industry average Stock P/E: 57.09)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 16.91%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Personal Care | Unilever House, B D Sawant Marg, Mumbai Maharashtra 400099 | levercare.shareholder@unilever.com http://www.hul.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Nitin Paranjpe | Chairman & Non-Exe.Director |
| Mr. Rohit Jawa | Managing Director & CEO |
| Mr. Ritesh Tiwari | Executive Director & CFO |
| Mr. Leo Puri | Independent Director |
| Ms. Ashu Suyash | Independent Director |
| Mr. Ranjay Gulati | Independent Director |
| Ms. Neelam Dhawan | Independent Director |
| Mr. Tarun Bajaj | Independent Director |
| Mr. Biddappa Ponnappa Bittianda | Executive Director |
FAQ
What is the intrinsic value of Hindustan Unilever Ltd?
Hindustan Unilever Ltd's intrinsic value (as of 30 November 2025) is 1897.42 which is 22.62% lower the current market price of 2,452.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 5,75,966 Cr. market cap, FY2025-2026 high/low of 2,780/2,136, reserves of ₹48,481 Cr, and liabilities of 82,034 Cr.
What is the Market Cap of Hindustan Unilever Ltd?
The Market Cap of Hindustan Unilever Ltd is 5,75,966 Cr..
What is the current Stock Price of Hindustan Unilever Ltd as on 30 November 2025?
The current stock price of Hindustan Unilever Ltd as on 30 November 2025 is 2,452.
What is the High / Low of Hindustan Unilever Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Hindustan Unilever Ltd stocks is 2,780/2,136.
What is the Stock P/E of Hindustan Unilever Ltd?
The Stock P/E of Hindustan Unilever Ltd is 54.4.
What is the Book Value of Hindustan Unilever Ltd?
The Book Value of Hindustan Unilever Ltd is 207.
What is the Dividend Yield of Hindustan Unilever Ltd?
The Dividend Yield of Hindustan Unilever Ltd is 1.75 %.
What is the ROCE of Hindustan Unilever Ltd?
The ROCE of Hindustan Unilever Ltd is 27.8 %.
What is the ROE of Hindustan Unilever Ltd?
The ROE of Hindustan Unilever Ltd is 20.7 %.
What is the Face Value of Hindustan Unilever Ltd?
The Face Value of Hindustan Unilever Ltd is 1.00.
